Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.

Item

http://www.wikidata.org/entity/Q38960128

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Combination of systemic chemot ...... RAIL in resected brain tumors.

@en

type

Item

label

Combination of systemic chemot ...... RAIL in resected brain tumors.

@en

prefLabel

Combination of systemic chemot ...... RAIL in resected brain tumors.

@en

P1476

Combination of systemic chemot ...... RAIL in resected brain tumors.

@en

P2093

Khalid Shah

http://www.w3.org/2001/XMLSchema#string

Navid Redjal

http://www.w3.org/2001/XMLSchema#string

Yanni Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer.

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux

Heterogeneity maintenance in glioblastoma: a social network

Cost of migration: invasion of malignant gliomas and implications for treatment.

Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway.

Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis.

P304

101-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.1834

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265297007

http://www.w3.org/2001/XMLSchema#string

P698

25186100

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

4270944

http://www.w3.org/2001/XMLSchema#string